Global Sterile Formulation Development Market 2023 by Company, Regions, Type and Application, Forecast to 2029

1 Market Overview

• 1.1 Product Overview and Scope of Sterile Formulation Development
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Sterile Formulation Development by Type
  • 1.3.1 Overview: Global Sterile Formulation Development Market Size by Type: 2018 Versus 2022 Versus 2029
  • 1.3.2 Global Sterile Formulation Development Consumption Value Market Share by Type in 2022
  • 1.3.3 Liquid Dosage Form
  • 1.3.4 Lyophilized Dosage Form
  • 1.3.5 Frozen Dosage Form
  • 1.3.6 Others
• 1.4 Global Sterile Formulation Development Market by Application
  • 1.4.1 Overview: Global Sterile Formulation Development Market Size by Application: 2018 Versus 2022 Versus 2029
  • 1.4.2 Preclinical
  • 1.4.3 Clinical
  • 1.4.4 Commercial
• 1.5 Global Sterile Formulation Development Market Size & Forecast
• 1.6 Global Sterile Formulation Development Market Size and Forecast by Region
  • 1.6.1 Global Sterile Formulation Development Market Size by Region: 2018 VS 2022 VS 2029
  • 1.6.2 Global Sterile Formulation Development Market Size by Region, (2018-2029)
  • 1.6.3 North America Sterile Formulation Development Market Size and Prospect (2018-2029)
  • 1.6.4 Europe Sterile Formulation Development Market Size and Prospect (2018-2029)
  • 1.6.5 Asia-Pacific Sterile Formulation Development Market Size and Prospect (2018-2029)
  • 1.6.6 South America Sterile Formulation Development Market Size and Prospect (2018-2029)
  • 1.6.7 Middle East and Africa Sterile Formulation Development Market Size and Prospect (2018-2029)

2 Company Profiles

• 2.1 Dalton Pharma Services
  • 2.1.1 Dalton Pharma Services Details
  • 2.1.2 Dalton Pharma Services Major Business
  • 2.1.3 Dalton Pharma Services Sterile Formulation Development Product and Solutions
  • 2.1.4 Dalton Pharma Services Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.1.5 Dalton Pharma Services Recent Developments and Future Plans
• 2.2 PCI Pharma Services
  • 2.2.1 PCI Pharma Services Details
  • 2.2.2 PCI Pharma Services Major Business
  • 2.2.3 PCI Pharma Services Sterile Formulation Development Product and Solutions
  • 2.2.4 PCI Pharma Services Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.2.5 PCI Pharma Services Recent Developments and Future Plans
• 2.3 Bioprocess Online
  • 2.3.1 Bioprocess Online Details
  • 2.3.2 Bioprocess Online Major Business
  • 2.3.3 Bioprocess Online Sterile Formulation Development Product and Solutions
  • 2.3.4 Bioprocess Online Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.3.5 Bioprocess Online Recent Developments and Future Plans
• 2.4 Farbe Firma
  • 2.4.1 Farbe Firma Details
  • 2.4.2 Farbe Firma Major Business
  • 2.4.3 Farbe Firma Sterile Formulation Development Product and Solutions
  • 2.4.4 Farbe Firma Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.4.5 Farbe Firma Recent Developments and Future Plans
• 2.5 Anglo Bio-Pharma Limited
  • 2.5.1 Anglo Bio-Pharma Limited Details
  • 2.5.2 Anglo Bio-Pharma Limited Major Business
  • 2.5.3 Anglo Bio-Pharma Limited Sterile Formulation Development Product and Solutions
  • 2.5.4 Anglo Bio-Pharma Limited Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.5.5 Anglo Bio-Pharma Limited Recent Developments and Future Plans
• 2.6 Thermo Fisher Scientific
  • 2.6.1 Thermo Fisher Scientific Details
  • 2.6.2 Thermo Fisher Scientific Major Business
  • 2.6.3 Thermo Fisher Scientific Sterile Formulation Development Product and Solutions
  • 2.6.4 Thermo Fisher Scientific Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans
• 2.7 Pfizer CentreOne
  • 2.7.1 Pfizer CentreOne Details
  • 2.7.2 Pfizer CentreOne Major Business
  • 2.7.3 Pfizer CentreOne Sterile Formulation Development Product and Solutions
  • 2.7.4 Pfizer CentreOne Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.7.5 Pfizer CentreOne Recent Developments and Future Plans
• 2.8 Piramal Pharma Solutions
  • 2.8.1 Piramal Pharma Solutions Details
  • 2.8.2 Piramal Pharma Solutions Major Business
  • 2.8.3 Piramal Pharma Solutions Sterile Formulation Development Product and Solutions
  • 2.8.4 Piramal Pharma Solutions Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.8.5 Piramal Pharma Solutions Recent Developments and Future Plans
• 2.9 Ardena
  • 2.9.1 Ardena Details
  • 2.9.2 Ardena Major Business
  • 2.9.3 Ardena Sterile Formulation Development Product and Solutions
  • 2.9.4 Ardena Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.9.5 Ardena Recent Developments and Future Plans
• 2.10 Curida
  • 2.10.1 Curida Details
  • 2.10.2 Curida Major Business
  • 2.10.3 Curida Sterile Formulation Development Product and Solutions
  • 2.10.4 Curida Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.10.5 Curida Recent Developments and Future Plans
• 2.11 Curia Global
  • 2.11.1 Curia Global Details
  • 2.11.2 Curia Global Major Business
  • 2.11.3 Curia Global Sterile Formulation Development Product and Solutions
  • 2.11.4 Curia Global Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.11.5 Curia Global Recent Developments and Future Plans
• 2.12 Carbogen Amcis
  • 2.12.1 Carbogen Amcis Details
  • 2.12.2 Carbogen Amcis Major Business
  • 2.12.3 Carbogen Amcis Sterile Formulation Development Product and Solutions
  • 2.12.4 Carbogen Amcis Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.12.5 Carbogen Amcis Recent Developments and Future Plans
• 2.13 Woodstock Sterile Solutions
  • 2.13.1 Woodstock Sterile Solutions Details
  • 2.13.2 Woodstock Sterile Solutions Major Business
  • 2.13.3 Woodstock Sterile Solutions Sterile Formulation Development Product and Solutions
  • 2.13.4 Woodstock Sterile Solutions Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.13.5 Woodstock Sterile Solutions Recent Developments and Future Plans
• 2.14 Cambrex
  • 2.14.1 Cambrex Details
  • 2.14.2 Cambrex Major Business
  • 2.14.3 Cambrex Sterile Formulation Development Product and Solutions
  • 2.14.4 Cambrex Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.14.5 Cambrex Recent Developments and Future Plans
• 2.15 Aenova Group
  • 2.15.1 Aenova Group Details
  • 2.15.2 Aenova Group Major Business
  • 2.15.3 Aenova Group Sterile Formulation Development Product and Solutions
  • 2.15.4 Aenova Group Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.15.5 Aenova Group Recent Developments and Future Plans
• 2.16 Lonza
  • 2.16.1 Lonza Details
  • 2.16.2 Lonza Major Business
  • 2.16.3 Lonza Sterile Formulation Development Product and Solutions
  • 2.16.4 Lonza Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.16.5 Lonza Recent Developments and Future Plans
• 2.17 Catalent
  • 2.17.1 Catalent Details
  • 2.17.2 Catalent Major Business
  • 2.17.3 Catalent Sterile Formulation Development Product and Solutions
  • 2.17.4 Catalent Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.17.5 Catalent Recent Developments and Future Plans
• 2.18 PPD
  • 2.18.1 PPD Details
  • 2.18.2 PPD Major Business
  • 2.18.3 PPD Sterile Formulation Development Product and Solutions
  • 2.18.4 PPD Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.18.5 PPD Recent Developments and Future Plans
• 2.19 Althea
  • 2.19.1 Althea Details
  • 2.19.2 Althea Major Business
  • 2.19.3 Althea Sterile Formulation Development Product and Solutions
  • 2.19.4 Althea Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.19.5 Althea Recent Developments and Future Plans
• 2.20 Baxter
  • 2.20.1 Baxter Details
  • 2.20.2 Baxter Major Business
  • 2.20.3 Baxter Sterile Formulation Development Product and Solutions
  • 2.20.4 Baxter Sterile Formulation Development Revenue, Gross Margin and Market Share (2018-2023)
  • 2.20.5 Baxter Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Sterile Formulation Development Revenue and Share by Players (2018-2023)
• 3.2 Market Share Analysis (2022)
  • 3.2.1 Market Share of Sterile Formulation Development by Company Revenue
  • 3.2.2 Top 3 Sterile Formulation Development Players Market Share in 2022
  • 3.2.3 Top 6 Sterile Formulation Development Players Market Share in 2022
• 3.3 Sterile Formulation Development Market: Overall Company Footprint Analysis
  • 3.3.1 Sterile Formulation Development Market: Region Footprint
  • 3.3.2 Sterile Formulation Development Market: Company Product Type Footprint
  • 3.3.3 Sterile Formulation Development Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Sterile Formulation Development Consumption Value and Market Share by Type (2018-2023)
• 4.2 Global Sterile Formulation Development Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

• 5.1 Global Sterile Formulation Development Consumption Value Market Share by Application (2018-2023)
• 5.2 Global Sterile Formulation Development Market Forecast by Application (2024-2029)

6 North America

• 6.1 North America Sterile Formulation Development Consumption Value by Type (2018-2029)
• 6.2 North America Sterile Formulation Development Consumption Value by Application (2018-2029)
• 6.3 North America Sterile Formulation Development Market Size by Country
  • 6.3.1 North America Sterile Formulation Development Consumption Value by Country (2018-2029)
  • 6.3.2 United States Sterile Formulation Development Market Size and Forecast (2018-2029)
  • 6.3.3 Canada Sterile Formulation Development Market Size and Forecast (2018-2029)
  • 6.3.4 Mexico Sterile Formulation Development Market Size and Forecast (2018-2029)

7 Europe

• 7.1 Europe Sterile Formulation Development Consumption Value by Type (2018-2029)
• 7.2 Europe Sterile Formulation Development Consumption Value by Application (2018-2029)
• 7.3 Europe Sterile Formulation Development Market Size by Country
  • 7.3.1 Europe Sterile Formulation Development Consumption Value by Country (2018-2029)
  • 7.3.2 Germany Sterile Formulation Development Market Size and Forecast (2018-2029)
  • 7.3.3 France Sterile Formulation Development Market Size and Forecast (2018-2029)
  • 7.3.4 United Kingdom Sterile Formulation Development Market Size and Forecast (2018-2029)
  • 7.3.5 Russia Sterile Formulation Development Market Size and Forecast (2018-2029)
  • 7.3.6 Italy Sterile Formulation Development Market Size and Forecast (2018-2029)

8 Asia-Pacific

• 8.1 Asia-Pacific Sterile Formulation Development Consumption Value by Type (2018-2029)
• 8.2 Asia-Pacific Sterile Formulation Development Consumption Value by Application (2018-2029)
• 8.3 Asia-Pacific Sterile Formulation Development Market Size by Region
  • 8.3.1 Asia-Pacific Sterile Formulation Development Consumption Value by Region (2018-2029)
  • 8.3.2 China Sterile Formulation Development Market Size and Forecast (2018-2029)
  • 8.3.3 Japan Sterile Formulation Development Market Size and Forecast (2018-2029)
  • 8.3.4 South Korea Sterile Formulation Development Market Size and Forecast (2018-2029)
  • 8.3.5 India Sterile Formulation Development Market Size and Forecast (2018-2029)
  • 8.3.6 Southeast Asia Sterile Formulation Development Market Size and Forecast (2018-2029)
  • 8.3.7 Australia Sterile Formulation Development Market Size and Forecast (2018-2029)

9 South America

• 9.1 South America Sterile Formulation Development Consumption Value by Type (2018-2029)
• 9.2 South America Sterile Formulation Development Consumption Value by Application (2018-2029)
• 9.3 South America Sterile Formulation Development Market Size by Country
  • 9.3.1 South America Sterile Formulation Development Consumption Value by Country (2018-2029)
  • 9.3.2 Brazil Sterile Formulation Development Market Size and Forecast (2018-2029)
  • 9.3.3 Argentina Sterile Formulation Development Market Size and Forecast (2018-2029)

10 Middle East & Africa

• 10.1 Middle East & Africa Sterile Formulation Development Consumption Value by Type (2018-2029)
• 10.2 Middle East & Africa Sterile Formulation Development Consumption Value by Application (2018-2029)
• 10.3 Middle East & Africa Sterile Formulation Development Market Size by Country
  • 10.3.1 Middle East & Africa Sterile Formulation Development Consumption Value by Country (2018-2029)
  • 10.3.2 Turkey Sterile Formulation Development Market Size and Forecast (2018-2029)
  • 10.3.3 Saudi Arabia Sterile Formulation Development Market Size and Forecast (2018-2029)
  • 10.3.4 UAE Sterile Formulation Development Market Size and Forecast (2018-2029)

11 Market Dynamics

• 11.1 Sterile Formulation Development Market Drivers
• 11.2 Sterile Formulation Development Market Restraints
• 11.3 Sterile Formulation Development Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry
• 11.5 Influence of COVID-19 and Russia-Ukraine War
  • 11.5.1 Influence of COVID-19
  • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

• 12.1 Sterile Formulation Development Industry Chain
• 12.2 Sterile Formulation Development Upstream Analysis
• 12.3 Sterile Formulation Development Midstream Analysis
• 12.4 Sterile Formulation Development Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source